Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment

BACKGROUND: The risk of serious infectious events (SIEs) is increased in patients with rheumatoid arthritis (RA). The aim of this study was to develop an age-adjusted comorbidity index (AACI) to predict, using baseline characteristics, the SIE risk in patients with RA treated with certolizumab pegol...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Winthrop, Kevin, O’Brien, Cathy, Ndlovu, Matladi N., de Longueville, Marc, Haraoui, Boulos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732488/
https://www.ncbi.nlm.nih.gov/pubmed/29246162
http://dx.doi.org/10.1186/s13075-017-1466-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732488/
https://www.ncbi.nlm.nih.gov/pubmed/29246162
http://dx.doi.org/10.1186/s13075-017-1466-y

Ejemplares similares